The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.
With pharmacy prices rising and healthcare budgets tight, the smartest move in 2026 isn't picking a single retailer—it's mastering the art of stacking discounts across both CVS and Walgreens. By ...